Skip to main content
Log in

Gender- and age-related differences in the endocrine parameters of acromegaly

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Acromegaly is a severe slow-developing disease associated with a poor prognosis for cardiovascular disease. To evaluate the impact of age and gender on the severity of the disease, 151 de novo patients with acromegaly (79 women, 72 men, age range 19–77 yr) were included in this open retrospective multi-center cohort study. Basal GH and IGF-I levels, GH response after glucose load and maximal tumor diameter at MRI were measured in all patients at diagnosis. Fasting GH levels and maximal tumor diameter were similar in women and men, while serum IGF-I levels were lower (664.9±24.9 vs 755.9±32 μg/l; p=0.02) and GH nadir after glucose load was higher (27.5±3.7 vs 18.5±2.2 μg/l; p=0.04) in women than in men. In both sexes, patients’ age was negatively correlated with basal and nadir GH, IGF-I levels and tumor size; fasting GH levels were positively correlated with IGF-I levels and nadir GH after glucose. No interaction between age and gender was found on biochemical and morphological parameters. At diagnosis, elderly patients with acromegaly have lower GH and IGF-I levels, lower GH nadir after glucose load and smaller adenomas than young patients. Women have lower IGF-I levels but higher GH nadir after glucose load than men. These age and gender differences should be considered to appropriately evaluate the activity of acromegaly throughout a life-span.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Colao A., Lombardi G. Growth-hormone and prolactin excess. Lancet 1998, 352: 1455–1461.

    Article  PubMed  CAS  Google Scholar 

  2. Ezzat S. Acromegaly. Endocrinol. Metab. Clin. North Am. 1997, 26: 703–723.

    Article  CAS  Google Scholar 

  3. Melmed S., Ho K., Klibanski A., Reichlin S., Thorner M.O. Recent advances in pathogenesis, diagnosis and management of acromegaly. J. Clin. Endocrinol. Metab. 1995, 80: 3395–3402.

    PubMed  CAS  Google Scholar 

  4. Losa M. Pituitary tumors in the elderly. Eur. J. Endocrinol. 1999, 140: 378–380.

    Article  PubMed  CAS  Google Scholar 

  5. Lamberts S.W.J., van der Lely A.J., de Herder W.W. Clinical and medical diagnosis of acromegaly. Metabolism 1995, 44: 15–19.

    Article  CAS  Google Scholar 

  6. Bates A.S., Van’t Hoff W., Jones J.M., Clayton R.N. An audit of outcome of treatment in acromegaly. Q. J. Med. 1993, 86: 293–299.

    PubMed  CAS  Google Scholar 

  7. Bengtsson B.A., Edén S., Ernest I., Oden A., Sjögren B. Epidemiology and long term survival in acromegaly. Acta Med. Scand. 1988, 223: 327–335.

    Article  PubMed  CAS  Google Scholar 

  8. Orme S.M., McNally R.J.Q., Cartwright R.A., Belchetz P.E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J. Clin. Endocrinol. Metab. 1998, 83: 2730–2734.

    PubMed  CAS  Google Scholar 

  9. Rajasoorya C, Holdaway I.M., Wrightson P., Scott D.J., Ibbertson H.K. Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. (Oxf.) 1994, 41: 95–102.

    Article  CAS  Google Scholar 

  10. Wright A.D., Hill D.M., Lowy C, Russell Fraser T. Mortality in acromegaly. Q.J.M. 1970, 153: 1–16.

    Google Scholar 

  11. Ghigo E., Aimaretti G., Gianotti L., Bellone J., Arvat E., Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 1996, 134: 352–356.

    Article  PubMed  CAS  Google Scholar 

  12. Zadik Z., Chalew S.A., McCarter R.J. Jr., Meistas M., Kowarski A.A. The influence of age on the 24 hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 1985, 60: 513–516.

    Article  PubMed  CAS  Google Scholar 

  13. Giustina A., Barkan A., Casanueva F.F., et al. Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 2000, 85: 526–529.

    PubMed  CAS  Google Scholar 

  14. Mancini A., Zuppi P., Fiumara C, et al. GH response to oral and intravenous glucose load in acromegalic patients. Horm. Metab. Res. 1995, 27: 322–325.

    Article  PubMed  CAS  Google Scholar 

  15. Melmed S., Jackson I., Kleinberg D., Klibanski A. Current treatment guidelines for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 2646–2652.

    PubMed  CAS  Google Scholar 

  16. Turner H.E., Adams C.B.T., Wass J.A.H. Pituitary tumours in the elderly: a 20 year experience. Eur. J. Endocrinol. 1999, 140: 383–389.

    Article  PubMed  CAS  Google Scholar 

  17. van der Lely A.J., Harris A.G., Lamberts S.W. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin. Endocrinol. (Oxf.) 1992, 37: 181–185.

    Article  Google Scholar 

  18. Frantz A.G., Rabkin M.T. Effects of estrogen and sex difference on secretion of human growth hormone. J. Clin. Endocrinol. Metab. 1965, 25: 1470–1480.

    Article  PubMed  CAS  Google Scholar 

  19. Ho K.Y., Evans W.S., Blizzard R.M., et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab. 1987, 64: 51–58.

    Article  PubMed  CAS  Google Scholar 

  20. Thompson R.G., Rodriguez A., Kowarski, A., Blizzard R.M. Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effects of prednisone. J. Clin. Invest. 1972, 51: 3193–3199.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Burman P., Johansson A., Siegbahn A., Vesby B., Karlsson F.A. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J. Clin. Endocrinol. Metab. 1997, 82: 550–555.

    PubMed  CAS  Google Scholar 

  22. Johansson A.G. Gender difference in growth hormone response in adults. J. Endocrinol. Invest. 1999, 22: 58–60.

    PubMed  CAS  Google Scholar 

  23. Johansson A.G., Engstrom B.E., Ljunghall S., Karlsson F.A., Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J. Clin. Endocrinol. Metab. 1999, 84: 2002–2007.

    PubMed  CAS  Google Scholar 

  24. Kaltsas G.A., Mukherjee J.J., Jenkins P.J., et al. Menstrual irregularity in women with acromegaly. J. Clin. Endocrinol. Metab. 1999, 84: 2731–2735.

    Article  PubMed  CAS  Google Scholar 

  25. Colao A., Ferone D., Lastoria S., et al. Prediction of efficacy of octreotide therapy in patients with acromegaly. J. Clin. Endocrinol. Metab. 1996, 81: 2356–2362.

    PubMed  CAS  Google Scholar 

  26. Colao A., Merola B., Ferone D., Lombardi G. Acromegaly. J. Clin. Endocrinol. Metab. 1997, 82: 2777–2781.

    Article  PubMed  CAS  Google Scholar 

  27. Smals A.E.M., Pieters G.F.F.M., Smals A.G.H., Kloppen-borg P.W.C. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly. Acta Endocrinol. 1988, 117: 387–391.

    Article  PubMed  CAS  Google Scholar 

  28. Winer L.M., Shaw M.A., Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J. Clin. Endocrinol. Metab. 1990, 70: 1678–1686.

    Article  PubMed  CAS  Google Scholar 

  29. van den Berg G., Veldhuis J.D., Frolich M., Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and pre-menopausal women. J. Clin. Endocrinol. Metab. 1996, 81: 2460–2467.

    PubMed  Google Scholar 

  30. Gatford K.L., Egan A.R., Clarke I.J., Owens P.C. Sexual dimorphism of the somatotrophic axis. J. Endocrinol. 1998, 157: 373–389.

    Article  PubMed  CAS  Google Scholar 

  31. Jaffe C.A., Ocampo-Lim B., Guo W., et al. Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J. Clin. Invest. 1998, 102: 153–164.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Chapman I.M., Hartmann M.L., Straume M., et al. Enhanced sensitivity growth hormone (GH) chemilumi-nescence assay reveals lower postglucose nadir GH concentrations in men than women. J. Clin. Endocrinol. Metab. 1994, 78: 1312–1319.

    PubMed  CAS  Google Scholar 

  33. Ferone D., Colao A., van der Lely A.J., Lamberts S.W.J. Pharmacotherapy or surgery as primary treatment for acromegaly? Drugs 2000, 17: 81–92.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Colao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colao, A., Amato, G., Pedroncelli, A.M. et al. Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest 25, 532–538 (2002). https://doi.org/10.1007/BF03345496

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345496

Key-words

Navigation